Home › Funds › Greg Jennings, LLC › DGX

Greg Jennings, LLC position in DGX

QUEST DIAGNOSTICS INC · Health Care

Greg Jennings, LLC reported holding 3,279 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$764K, representing 0.54% of its reported portfolio and ranking #34 among its reported holdings. Greg Jennings, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)3.28K sh
Reported value held$764.24K
Portfolio Weight0.54%
First reportedQ3 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Greg Jennings, LLC's DGX position evolved

Greg Jennings, LLC first disclosed a stake in DGX in Q3 2026 at 3,279 shares (US$764K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 3.28K $764.24K New

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Greg Jennings, LLC held DGX?

Greg Jennings, LLC has disclosed DGX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Greg Jennings, LLC's current position in DGX?

As of Q3 2026, Greg Jennings, LLC holds 3.28K shares of DGX (QUEST DIAGNOSTICS INC), valued at $764.24K, representing 0.54% of its reported portfolio and ranking #34.

Has Greg Jennings, LLC been buying or selling DGX?

In the latest 13F filing (Q3 2026), Greg Jennings, LLC newly opened its position in DGX.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.